Marimed (MRMD) Interest Expenses (2012 - 2026)

Marimed (MRMD) has 14 years of Interest Expenses data on file, last reported at $14.5 million in Q1 2026.

• On a quarterly basis, Interest Expenses rose 566.73% year-over-year to $14.5 million in Q1 2026; TTM through Mar 2026 was $14.5 million, a 566.73% increase from a year earlier, with the FY2025 full-year figure at $7.5 million, down 58.63% from the prior year.
• Interest Expenses for Q1 2026 stood at $14.5 million, up from $2.3 million in the prior quarter.
• Over the last five years, Interest Expenses for MRMD reached as high as $15.4 million in Q3 2025 and fell as low as -$8.1 million in Q1 2024.
• Historically, Interest Expenses has averaged $3.7 million across 5 years, with a median of $1.9 million in 2024.
• On a YoY basis, Interest Expenses climbed as much as 1074.48% in 2023 and fell as far as 444.71% in 2023.
• Year by year, Interest Expenses stood at $422000.0 in 2022, then surged by 110.43% to $888000.0 in 2023, then soared by 112.39% to $1.9 million in 2024, then advanced by 22.43% to $2.3 million in 2025, then soared by 527.63% to $14.5 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $14.5 million in Q1 2026, $2.3 million in Q4 2025, and $15.4 million in Q3 2025.